Merck’s (MRK) animal health unit announced that the U.S. FDA approved a label expansion for its once-yearly parasiticide treatment Bravecto Quantum to treat two additional tick species in dogs.
Many of us are far too familiar with the term “arthritis.” Well, so are many of our dogs. The arthritis most of our dogs get is known as osteoarthritis, or OA. It is a challenging disease involving ...
Merck Animal Health, known as MSD Animal Health outside the United States and Canada, a division of Merck & Co., Inc., Rahway ...
A dog mom has shared her senior dog's remarkable recovery after receiving Librela injections to relieve her osteoarthritis symptoms. Sara (@sararenea96) posted the heartwarming journey of her now ...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS) today announced that the U.S. Food and Drug Administration (FDA) has approved Librela™ (bedinvetmab injection) for the control of pain ...
Fleas present a constant threat for any dog parent. Not only are fleas disgusting, but they can also cause blood loss, skin irritation, and other problems in dogs. Fortunately, there are many ways to ...
First long-acting canine anti-nerve growth factor monoclonal antibody therapy administered once every three months Approval marks major milestone in the company’s continued innovation for canine OA ...